State-of-the-art treatment alternatives for base of skull meningiomas: Complementing and controversial indications for neurosurgery, stereotactic and robotic based radiosurgery or modern fractionated radiation techniques

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Combs, Stephanie E ^a   Ganswindt, Ute ^d   Foote, Robert L ^b   Kondziolka, Douglas ^c   Tonn, Jörg Christian ^d  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b MAYO CLINIC   (United States)

^c NEW YORK UNIVERSITY   (United States)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CRANIAL NERVE INJURY; FRACTIONATED STEREOTACTIC RADIOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; MENINGIOMA; MICROSURGERY; NEUROSURGERY; RADIATION INJURY; RADIOSURGERY; REVIEW; ROBOTICS; SKULL BASE MENINGIOMA; SKULL BASE TUMOR; STEREOTAXIC SURGERY;

DOSE FRACTIONATION; HUMANS; MENINGIOMA; RADIOSURGERY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; ROBOTICS; SKULL BASE NEOPLASMS; TREATMENT OUTCOME;

EID: 84871588074     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-226     Document Type: Review

References (68)

1. Arthurs BJ, Fairbanks RK, Demakas JJ, Lamoreaux WT, Giddings NA, Mackay AR, et al. A review of treatment modalities for vestibular schwannoma. Neurosurg Rev 2011, 34:265-277. 10.1007/s10143-011-0307-8, 21305333.
2. Bindal R, Goodman JM, Kawasaki A, Purvin V, Kuzma B. The natural history of untreated skull base meningiomas. Surg Neurol 2003, 59:87-92. 10.1016/S0090-3019(02)00995-3, 12648902.
3. Rachinger W, Grau S, Tonn JC. Different microsurgical approaches to meningiomas of the anterior cranial base. Acta Neurochir (Wien) 2010, 152:931-939.
4. Westphal M, Lamszus K, Tonn JC. Meningiomas and meningeal tumors. Oncology of CNS tumors 2010, 95-118. Heidelberg, New York: Springer, Tonn JC, Westphal M, Rutka J, 2.
5. Pechlivanis I, Wawrzyniak S, Engelhardt M, Schmieder K. Evidence level in the treatment of meningioma with focus on the comparison between surgery versus radiotherapy. A review. J Neurosurg Sci 2011, 55:319-328.
6. Komotar RJ, Starke RM, Raper DM, Anand VK, Schwartz TH. Endoscopic endonasal versus open transcranial resection of anterior midline skull base meningiomas. World Neurosurg 2012, 77:713-724. 10.1016/j.wneu.2011.08.025, 22120296.
7. Kang CS, Zheng LG, Xu DS. Dose-volume effect in gamma knife radiosurgery of meningiomas. Stereotact Funct Neurosurg 1999, 73:72-78. 10.1159/000029758, 10853105.
8. Morita A, Coffey RJ, Foote RL, Schiff D, Gorman D. Risk of injury to cranial nerves after gamma knife radiosurgery for skull base meningiomas: experience in 88 patients. J Neurosurg 1999, 90:42-49. 10.3171/jns.1999.90.1.0042, 10413154.
9. Flickinger JC, Kondziolka D, Niranjan A, Lunsford LD. Dose selection in stereotactic radiosurgery. Prog Neurol Surg 2007, 20:28-42.
10. Mayo C, Martel MK, Marks LB, Flickinger J, Nam J, Kirkpatrick J. Radiation dose-volume effects of optic nerves and chiasm. Int J Radiat Oncol Biol Phys 2010, 76:S28-S35. 10.1016/j.ijrobp.2009.07.1753, 20171514.
11. Theelen A, Martens J, Bosmans G, Houben R, Jager JJ, Rutten I, et al. Relocatable fixation systems in intracranial stereotactic radiotherapy. Accuracy of serial CT scans and patient acceptance in a randomized design. Strahlenther Onkol 2012, 188:84-90. 10.1007/s00066-011-0018-7, 22194025.
12. Debus J, Wuendrich M, Pirzkall A, Hoess A, Schlegel W, Zuna I, et al. High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: long-term results. J Clin Oncol 2001, 19:3547-3553.
13. Pirzkall A, Carol M, Lohr F, Hoss A, Wannenmacher M, Debus J. Comparison of intensity-modulated radiotherapy with conventional conformal radiotherapy for complex-shaped tumors. Int J Radiat Oncol Biol Phys 2000, 48:1371-1380. 10.1016/S0360-3016(00)00772-0, 11121636.
14. Combs SE, Edler L, Burkholder I, Rieken S, Habermehl D, Jakel O, et al. Treatment of patients with atypical meningiomas Simpson grade 4 and 5 with a carbon ion boost in combination with postoperative photon radiotherapy: the MARCIE trial. BMC Cancer 2010, 10:615. 10.1186/1471-2407-10-615, 2996393, 21062428.
15. Pollock BE, Stafford SL, Link MJ, Garces YI, Foote RL. Single-fraction radiosurgery for presumed intracranial meningiomas: efficacy and complications from a 22-year experience. Int J Radiat Oncol Biol Phys 2012, 83:1414-1418. 10.1016/j.ijrobp.2011.10.033, 22209154.
16. Novotny J, Kollova A, Liscak R. Prediction of intracranial edema after radiosurgery of meningiomas. J Neurosurg 2006, 105(Suppl):120-126.
17. Combs SE, Sterzing F, Uhl M, Habl G, Schubert K, Debus J, et al. Helical tomotherapy for meningiomas of the skull base and in paraspinal regions with complex anatomy and/or multiple lesions. Tumori 2011, 97:484-491.
18. Combs SE, Adeberg S, Dittmar JO, Welzel T, Rieken S, Habermehl D, et al. Skull base meningiomas: Long-term results and patient self-reported outcome in 507 patients treated with fractionated stereotactic radiotherapy (FSRT) or intensity modulated radiotherapy (IMRT). Radiother Oncol 2012, Aug. 17; epub ahead of print.
19. Hamm K, Henzel M, Gross MW, Surber G, Kleinert G, Engenhart-Cabillic R. Radiosurgery/stereotactic radiotherapy in the therapeutical concept for skull base meningiomas. Zentralbl Neurochir 2008, 69:14-21. 10.1055/s-2007-992138, 18393160.
20. Henzel M, Gross MW, Hamm K, Surber G, Kleinert G, Failing T, et al. Significant tumor volume reduction of meningiomas after stereotactic radiotherapy: results of a prospective multicenter study. Neurosurgery 2006, 59:1188-1194.
21. Henzel M, Gross MW, Hamm K, Surber G, Kleinert G, Failing T, et al. Stereotactic radiotherapy of meningiomas: symptomatology, acute and late toxicity. Strahlenther Onkol 2006, 182:382-388. 10.1007/s00066-006-1535-7, 16826356.
22. Minniti G, Clarke E, Cavallo L, Osti MF, Esposito V, Cantore G, et al. Fractionated stereotactic conformal radiotherapy for large benign skull base meningiomas. Radiat Oncol 2011, 6:36. 10.1186/1748-717X-6-36, 3094366, 21486436.
23. Minniti G, Amichetti M, Enrici RM. Radiotherapy and radiosurgery for benign skull base meningiomas. Radiat Oncol 2009, 4:42. 10.1186/1748-717X-4-42, 2768735, 19828022.
24. Chao ST, Thakkar VV, Barnett GH, Vogelbaum MA, Angelov L, Weil RJ, et al. Prospective study of the short-term adverse effects of gamma knife radiosurgery. Technol Cancer Res Treat 2012, 11:117-122.
25. Leber KA, Bergloff J, Pendl G. Dose-response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery. J Neurosurg 1998, 88:43-50. 10.3171/jns.1998.88.1.0043, 9420071.
26. Flannery TJ, Kano H, Lunsford LD, Sirin S, Tormenti M, Niranjan A, et al. Long-term control of petroclival meningiomas through radiosurgery. J Neurosurg 2010, 112:957-964. 10.3171/2009.8.JNS09695, 19731986.
27. Starke RM, Nguyen JH, Rainey J, Williams BJ, Sherman JH, Savage J, et al. Gamma Knife surgery of meningiomas located in the posterior fossa: factors predictive of outcome and remission. J Neurosurg 2011, 114:1399-1409.
28. Starke RM, Nguyen JH, Reames DL, Rainey J, Sheehan JP. Gamma knife radiosurgery of meningiomas involving the foramen magnum. J Craniovertebr Junction Spine 2010, 1:23-28. 10.4103/0974-8237.65478, 2944857, 20890411.
29. Nakaya K, Niranjan A, Kondziolka D, Kano H, Khan AA, Nettel B, et al. Gamma knife radiosurgery for benign tumors with symptoms from brainstem compression. Int J Radiat Oncol Biol Phys 2010, 77:988-995. 10.1016/j.ijrobp.2009.06.089, 20381265.
30. Kondziolka D, Flickinger JC, Lunsford LD. The principles of skull base radiosurgery. Neurosurg Focus 2008, 24:E11.
31. Kondziolka D, Mathieu D, Lunsford LD, Martin JJ, Madhok R, Niranjan A, et al. Radiosurgery as definitive management of intracranial meningiomas. Neurosurgery 2008, 62:53-58. 10.1227/01.NEU.0000311061.72626.0D, 18300891.
32. Ernst-Stecken A, Lambrecht U, Ganslandt O, Mueller R, Fahlbusch R, Sauer R, et al. Radiosurgery of small skull-base lesions. No advantage for intensity-modulated stereotactic radiosurgery versus conformal arc technique. Strahlenther Onkol 2005, 181:336-344. 10.1007/s00066-005-1371-1, 15900431.
33. Shrieve DC, Hazard L, Boucher K, Jensen RL. Dose fractionation in stereotactic radiotherapy for parasellar meningiomas: radiobiological considerations of efficacy and optic nerve tolerance. J Neurosurg 2004, 101(Suppl 3):390-395.
34. Sibtain A, Plowman PN. Stereotactic radiosurgery. VII. Radiosurgery versus conventionally-fractionated radiotherapy in the treatment of cavernous sinus meningiomas. Br J Neurosurg 1999, 13:158-166. 10.1080/02688699943925, 10616585.
35. Compter I, Zaugg K, Houben RM, Dings JT, Bosmans G, Buescher C, et al. High symptom improvement and local tumor control using stereotactic radiotherapy when given early after diagnosis of meningioma. A multicentre study. Strahlenther Onkol 2012, 188:887-893. 10.1007/s00066-012-0155-7, 22961046.
36. Alheit H, Saran FH, Warrington AP, Rosenberg I, Perks J, Jalali R, et al. Stereotactically guided conformal radiotherapy for meningiomas. Radiother Oncol 1999, 50:145-150. 10.1016/S0167-8140(98)00133-9, 10368037.
37. Maguire PD, Clough R, Friedman AH, Halperin EC. Fractionated external-beam radiation therapy for meningiomas of the cavernous sinus. Int J Radiat Oncol Biol Phys 1999, 44:75-79. 10.1016/S0360-3016(98)00558-6, 10219797.
38. Jalali R, Loughrey C, Baumert B, Perks J, Warrington AP, Traish D, et al. High precision focused irradiation in the form of fractionated stereotactic conformal radiotherapy (SCRT) for benign meningiomas predominantly in the skull base location. Clin Oncol (R Coll Radiol) 2002, 14:103-109.
39. Selch MT, Ahn E, Laskari A, Lee SP, Agazaryan N, Solberg TD, et al. Stereotactic radiotherapy for treatment of cavernous sinus meningiomas. Int J Radiat Oncol Biol Phys 2004, 59:101-111. 10.1016/j.ijrobp.2003.09.003, 15093905.
40. Onodera S, Aoyama H, Katoh N, Taguchi H, Yasuda K, Yoshida D, et al. Long-term outcomes of fractionated stereotactic radiotherapy for intracranial skull base benign meningiomas in single institution. Jpn J Clin Oncol 2011, 41:462-468. 10.1093/jjco/hyq231, 21177777.
41. Astner ST, Theodorou M, Dobrei-Ciuchendea M, Auer F, Kopp C, Molls M, et al. Tumor shrinkage assessed by volumetric MRI in the long-term follow-up after stereotactic radiotherapy of meningiomas. Strahlenther Onkol 2010, 186:423-429. 10.1007/s00066-010-2138-x, 20803282.
42. Steinvorth S, Welzel G, Fuss M, Debus J, Wildermuth S, Wannenmacher M, et al. Neuropsychological outcome after fractionated stereotactic radiotherapy (FSRT) for base of skull meningiomas: a prospective 1-year follow-up. Radiother Oncol 2003, 69:177-182. 10.1016/S0167-8140(03)00204-4, 14643955.
43. van Nieuwenhuizen D, Klein M, Stalpers LJ, Leenstra S, Heimans JJ, Reijneveld JC. Differential effect of surgery and radiotherapy on neurocognitive functioning and health-related quality of life in WHO grade I meningioma patients. J Neurooncol 2007, 84:271-278. 10.1007/s11060-007-9366-7, 17431545.
44. Baumert BG, Norton IA, Davis JB. Intensity-modulated stereotactic radiotherapy vs. stereotactic conformal radiotherapy for the treatment of meningioma located predominantly in the skull base. Int J Radiat Oncol Biol Phys 2003, 57:580-592. 10.1016/S0360-3016(03)00587-X, 12957272.
45. Pirzkall A, Debus J, Haering P, Rhein B, Grosser KH, Hoss A, et al. Intensity modulated radiotherapy (IMRT) for recurrent, residual, or untreated skull-base meningiomas: preliminary clinical experience. Int J Radiat Oncol Biol Phys 2003, 55:362-372. 10.1016/S0360-3016(02)03809-9, 12527049.
46. Milker-Zabel S, Zabel-du BA, Huber P, Schlegel W, Debus J. Intensity-modulated radiotherapy for complex-shaped meningioma of the skull base: long-term experience of a single institution. Int J Radiat Oncol Biol Phys 2007, 68:858-863. 10.1016/j.ijrobp.2006.12.073, 17379447.
47. Boskos C, Feuvret L, Noel G, Habrand JL, Pommier P, Alapetite C, et al. Combined proton and photon conformal radiotherapy for intracranial atypical and malignant meningioma. Int J Radiat Oncol Biol Phys 2009, 75:399-406. 10.1016/j.ijrobp.2008.10.053, 19203844.
48. Gudjonsson O, Blomquist E, Nyberg G, Pellettieri L, Montelius A, Grusell E, et al. Stereotactic irradiation of skull base meningiomas with high energy protons. Acta Neurochir (Wien) 1999, 141:933-940.
49. Halasz LM, Bussiere MR, Dennis ER, Niemierko A, Chapman PH, Loeffler JS, et al. Proton stereotactic radiosurgery for the treatment of benign meningiomas. Int J Radiat Oncol Biol Phys 2011, 81:1428-1435. 10.1016/j.ijrobp.2010.07.1991, 20934263.
50. Noel G, Bollet MA, Calugaru V, Feuvret L, Haie-Meder C, Dhermain F, et al. Functional outcome of patients with benign meningioma treated by 3D conformal irradiation with a combination of photons and protons. Int J Radiat Oncol Biol Phys 2005, 62:1412-1422. 10.1016/j.ijrobp.2004.12.048, 16029801.
51. Vernimmen FJ, Harris JK, Wilson JA, Melvill R, Smit BJ, Slabbert JP. Stereotactic proton beam therapy of skull base meningiomas. Int J Radiat Oncol Biol Phys 2001, 49:99-105. 10.1016/S0360-3016(00)01457-7, 11163502.
52. Weber DC, Lomax AJ, Rutz HP, Stadelmann O, Egger E, Timmermann B, et al. Spot-scanning proton radiation therapy for recurrent, residual or untreated intracranial meningiomas. Radiother Oncol 2004, 71:251-258. 10.1016/j.radonc.2004.02.011, 15172139.
53. Weber DC, Schneider R, Goitein G, Koch T, Ares C, Geismar JH, et al. Spot Scanning-based Proton Therapy for Intracranial Meningioma: Long-term Results from the Paul Scherrer Institute. Int J Radiat Oncol Biol Phys 2011,
54. Wenkel E, Thornton AF, Finkelstein D, Adams J, Lyons S, De La MS, et al. Benign meningioma: partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy. Int J Radiat Oncol Biol Phys 2000, 48:1363-1370. 10.1016/S0360-3016(00)01411-5, 11121635.
55. Arvold ND, Niemierko A, Broussard GP, Adams J, Fullerton B, Loeffler JS, et al. Projected second tumor risk and dose to neurocognitive structures after proton versus photon radiotherapy for benign meningioma. Int J Radiat Oncol Biol Phys 2012, 83:e495-e500. 10.1016/j.ijrobp.2011.10.056, 22285662.
56. Askoxylakis V, Zabel-du BA, Schlegel W, Debus J, Huber P, Milker-Zabel S. Patterns of failure after stereotactic radiotherapy of intracranial meningioma. J Neurooncol 2010, 98:367-372. 10.1007/s11060-009-0084-1, 20012910.
57. Schad LR, Gademann G, Knopp M, Zabel HJ, Schlegel W, Lorenz WJ. Radiotherapy treatment planning of basal meningiomas: improved tumor localization by correlation of CT and MR imaging data. Radiother Oncol 1992, 25:56-62. 10.1016/0167-8140(92)90196-2, 1410591.
58. Astner ST, Dobrei-Ciuchendea M, Essler M, Bundschuh RA, Sai H, Schwaiger M, et al. Effect of 11C-methionine-positron emission tomography on gross tumor volume delineation in stereotactic radiotherapy of skull base meningiomas. Int J Radiat Oncol Biol Phys 2008, 72:1161-1167. 10.1016/j.ijrobp.2008.02.058, 18440729.
59. Grosu AL, Weber WA, Astner ST, Adam M, Krause BJ, Schwaiger M, et al. 11C-methionine PET improves the target volume delineation of meningiomas treated with stereotactic fractionated radiotherapy. Int J Radiat Oncol Biol Phys 2006, 66:339-344. 10.1016/j.ijrobp.2006.02.047, 16765533.
60. Gehler B, Paulsen F, Oksuz MO, Hauser TK, Eschmann SM, Bares R, et al. [68 Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning. Radiat Oncol 2009, 4:56. 10.1186/1748-717X-4-56, 2785827, 19922642.
61. Graf R, Nyuyki F, Steffen IG, Michel R, Fahdt D, Wust P, et al. Contribution of (68)Ga-DOTATOC PET/CT to Target Volume Delineation of Skull Base Meningiomas Treated With Stereotactic Radiation Therapy 2012, Phys: Int J Radiat Oncol Biol.
62. DeMonte F, Smith HK, al Mefty O. Outcome of aggressive removal of cavernous sinus meningiomas. J Neurosurg 1994, 81:245-251. 10.3171/jns.1994.81.2.0245, 8027808.
63. Maier H, Ofner D, Hittmair A, Kitz K, Budka H. Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance. J Neurosurg 1992, 77:616-623. 10.3171/jns.1992.77.4.0616, 1527622.
64. Salcman M. Malignant meningiomas. Meningiomas 75, 85-1991. New York: Raven, Al-Mefty O, Ref Type: Abstract.
65. Goyal LK, Suh JH, Mohan DS, Prayson RA, Lee J, Barnett GH. Local control and overall survival in atypical meningioma: a retrospective study. Int J Radiat Oncol Biol Phys 2000, 46:57-61. 10.1016/S0360-3016(99)00349-1, 10656373.
66. Aghi MK, Carter BS, Cosgrove GR, Ojemann RG, Amin-Hanjani S, Martuza RL, et al. Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery 2009, 64:56-60. 10.1227/01.NEU.0000330399.55586.63, 19145156.
67. Dziuk TW, Woo S, Butler EB, Thornby J, Grossman R, Dennis WS, et al. Malignant meningioma: an indication for initial aggressive surgery and adjuvant radiotherapy. J Neurooncol 1998, 37:177-188. 10.1023/A:1005853720926, 9524097.
68. Engenhart-Cabillic R, Farhoud A, Sure U, Heinze S, Henzel M, Mennel HD, et al. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment. Strahlenther Onkol 2006, 182:641-646. 10.1007/s00066-006-1555-3, 17072521.